Temasek Seeks to Recoup Some Gains in Celltrion and Celltrion Healthcare
Posted on 03/07/2018
Ion Investments, a sovereign wealth enterprise of Singapore’s Temasek Holdings, is conducting a block sale on its holdings in South Korean pharmaceutical company Celltrion and distributor Celltrion Healthcare. The block deal is reportedly worth 1.2 trillion KRW – 828.8 billion KRW in Celltion and 346.2 billion KRW in Celltrion Healthcare. Temasek is looking to sell […]
